70 /100
HIGH RISK
Score updated May 30, 2026

OGEN — Oragenics, Inc. Dilution Risk Tracker

Track OGEN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OGEN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
35
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
56%
📜 Warrant Exercise 60%
• Massive warrant overhang: 306% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split 55%
• 50-day avg $0.62 below $1 exchange minimum
📉 Score Deterioration 50%
• Score rose 50 points recently (worsening)
• Score in HIGH risk zone (70/100)
🔔 Track OGEN — Get forecast alerts →

💹 Market Data

Market Cap$2.73M
Shares Outstanding4.51M
Float4.41M
Cash$6.11M
Debt$56.1K
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 190.1K shares
#1 Geode Capital Management, LLC 65.1K shares
#2 Pathstone Holdings, LLC 55.0K shares
#3 Two Sigma Securities, LLC 20.3K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest656.6K
Days to Cover11.8
% of Float14.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2021
xbrl XBRL CONVERTIBLE Dec 31, 2015
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track OGEN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OGEN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for OGEN
📊 OGEN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 OGEN Signal Convergence & Dark Pool Activity — StonkWhisper 📄 OGEN Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.